Task: Answer the multiple-choice question.
Question: Which drug exhibits a -18.594\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCn1c(C(=O)N2CCCC(C(=O)NCCCc3ccccc3)C2)cc2sccc21
(b) Cn1c(N2CCN(C(=O)NCc3ccccc3)CC2)nc2ccccc21
Answer: b. Cn1c(N2CCN(C(=O)NCc3ccccc3)CC2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(N2CCN(C(=O)NCc3ccccc3)CC2)nc2ccccc21
Cn1c(N2CCN(C(=O)NCc3ccccc3)CC2)nc2ccccc21
N-benzyl-4-(1-methylbenzimidazol-2-yl)piperazine-1-carboxamide